elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27310843-6005D0CE-494D-43B1-8DD5-DCC7EDAF744B
Q27310843-6005D0CE-494D-43B1-8DD5-DCC7EDAF744B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27310843-6005D0CE-494D-43B1-8DD5-DCC7EDAF744B
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.
P2860
Q27310843-6005D0CE-494D-43B1-8DD5-DCC7EDAF744B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27310843-6005D0CE-494D-43B1-8DD5-DCC7EDAF744B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
723d37ec9ace423665dc81abdc710491f58c02f1
P2860
MGMT gene silencing and benefit from temozolomide in glioblastoma.